By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ACADIA Pharmaceuticals, Inc. 

3911 Sorrento Valley Boulevard

San Diego  California  92121   U.S.A.
Phone: 858-558-2871 Fax: 858-558-2872


ACADIA is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders.


July 16, 1993


Founder: Mark Brann

CEO: Stephen Davis

CMO (Medical): Randall Owen


Please click here for Acadia Pharma job opportunities.


Please click here for clinical trial information.


All Products

Key Statistics

Ownership: Public

Web Site: Acadia
Employees: 140
Symbol: ACAD

Drug Discovery


Allergan  Discovery of alpha adrenergic drug candidates that may represent a significant breakthrough in the treatment of neuropathic pain.

Allergan  Develop and commercialize selective muscarinic drugs for the treatment of glaucoma.

Allergan  The third collaboration is designed to leverage ACADIA's R&D platform to discover and develop new therapeutics predominantly in the area of pain.

Sunovion  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.

Company News
Acadia (ACAD) Sponsors National Parkinson Foundation’s Caregiver Summit 9/19/2016 11:59:50 AM
Acadia (ACAD) To Present At The Morgan Stanley Global Healthcare Conference On September 12, 2016 9/6/2016 11:06:21 AM
Acadia (ACAD) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/24/2016 9:52:02 AM
Acadia (ACAD) Scores Former Baxalta (BXLT) Exec as New CFO 8/24/2016 7:10:00 AM
3 High-Risk, High-Reward Biotech Stocks 8/24/2016 6:15:40 AM
Acadia (ACAD) Prices Public Offering Of Common Stock 8/10/2016 9:46:15 AM
Acadia (ACAD) Announces Proposed Public Offering Of Common Stock 8/9/2016 11:16:13 AM
Acadia (ACAD) Reports Second Quarter 2016 Financial Results 8/5/2016 11:05:28 AM
Acadia (ACAD) To Announce Second Quarter 2016 Financial Results On August 4, 2016 8/1/2016 11:01:42 AM
Acadia (ACAD) To Present At The JMP Securities Life Sciences Conference On June 21, 2016 6/16/2016 10:19:44 AM